Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2037

Annual patent cliff calendar for 2037 — US pharmaceutical patents by expiration date.

Patents
1,615

Quick answer

1,615 indexed pharmaceutical patents have expiration dates in 2037. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9737640

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9738625

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9738624

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9738726

    HER2-specific monoclonal antibodies and conjugates thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9738721

    Oncostatin M receptor antigen binding proteins

    Kiniksa Pharmaceuticals, GmbH · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9738720

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9738641

    Bicyclic inhibitors

    KalVista Pharmaceuticals Limited · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9738629

    Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9737623

    Antibodies that bind activatable antibodies and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9737598

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9737530

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9737513

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9737478

    Treatment of malaria

    National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9737477

    Anti-aging dietary composition containing polysaccharides derived from ginseng and tuber fleeceflower root

    INFINITUS (CHINA) COMPANY LTD. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9737482

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9737503

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9737525

    Small molecule activators of NRF2 pathway

    The Regents of the University of California · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9737512

    Methods and compositions for treating chronic pain

    The Board of Regents of the University of Texas System · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9737527

    Biopolymer drug loading method

    SOUTH DAKOTA BOARD OF REGENTS · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9737500

    Compositions and methods for treating severe pain

    Infirst Healthcare Limited · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9745585

    RNAi-mediated inhibition of histamine receptor H1-related conditions

    Arrowhead Pharmaceuticals, Inc. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9745266

    Indoline alkaloid compounds

    The Regents of the University of Colorado · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9745376

    Anti-ανβ6 antibodies

    The Regents of the University of California · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9745314

    MDM2 inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9745255

    Meta-substituted biphenyl peripherally restricted FAAH inhibitors

    The Regents of the University of California · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9744235

    Treatment of cardiovascular disorders with targeted nanoparticles

    The Board of Regents of the University of Oklahoma · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9744163

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9744142

    Formulations of volatile anesthetics and methods of use for reducing inflammation

    The Board of Regents of the University of Texas System · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9744141

    Multifunctional nanoparticle designs and applications

    The Regents of the University of California · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9744137

    Topiramate compositions and methods of enhancing its bioavailability

    Supernus Pharmaceuticals, Inc. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9744126

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9744132

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9744194

    Methods of treating ischemic spasticity

    The Regents of the University of California · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9744146

    Method for alleviating disturbance of bile acid metabolism, amino acid metabolism, and/or gut microbiota metabolism

    China Medical University · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9744159

    Methods of treatment Rett syndrome

    OVID THERAPEUTICS INC. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9744169

    Compounds for treatment of fibrosis diseases

    Curegenix, Inc. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9744226

    Attenuated Mannheimia haemolytica strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9744214

    Methods and compositions for modulating myofibroblast activities

    The Regents of the University of California · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9745296

    Salts, co-crystals, and polymorphs of an anxiolytic compound

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9745325

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9745337

    Complex compounds of germanium, methods for producing same, and drugs

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU “WELDUP” · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9745572

    Method for identifying antibiotic targets

    DISCUVA LIMITED · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9745576

    RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

    BIOMARIN TECHNOLOGIES B.V. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9750845

    Biodegradable nanocomposites with enhanced mechanical properties for soft tissue engineering

    Northwestern University · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9751885

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9751893

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9751931

    Hepatitis C virus neutralizing antibodies and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9751932

    Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2037?

1,615 published patents in our USPTO index have expiration dates falling in calendar year 2037.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.